Professor, Medicine, Georgetown University School of Medicine
Cardiology
Dr. Charles E. Rackley, MD
|
|
Give Review
Doctor Charles E. Rackley, MD works in the field of Cardiology. He studied medicine at Duke University School of Medicine. Duke University School of Medicine is a one of the best medicals schools. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care He over the years received 5 awards: "Meaningful Use Stage 1 Certification", "Elected Member", "Distinguished Alumnus", "President" and "Fellow (FACC)". Doctor Charles E. Rackley, MD is a published MD as well. He has 59 publications published. The latest was: Metabolic consequences of glucose-insulin-potassium infusion in treatment of acute myocardial infarction. Dr. Charles E. Rackley accepts all Medicare patients.
Publications
- New clinical markers predictive of cardiovascular Disease: the role of inflammatory mediators.
- Hormones and Coronary atherosclerosis in women.
- Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.
- Vascular abnormalities in the metabolic syndrome: mechanisms and therapy.
- Glucose-insulin-potassium therapy in patients with STEMI.
- Strategies for the prevention of atherosclerotic progression in women.
- Role of statin drugs in acute Coronary syndromes.
- Cardiovascular basis for cholesterol therapy.
- Monotherapy with HMG-CoA reductase inhibitors and secondary prevention in coronary artery Disease.
- Advances in treatment of cholesterol abnormalities. The role of HMG-CoA reductase inhibitors.
- Reduction of hospital mortality rate of Acute myocardial infarction with glucose-insulin-potassium infusion.
- Glucose-insulin-potassium infusion in Acute myocardial infarction. Review of clinical experience.
- Prospective randomized trial of glucose-insulin-potassium in Acute myocardial infarction. Effects on myocardial hemodynamics, substrates and rhythm.
- Pulmonary consolidation associated with infusion of a glucose-insulin-potassium solution in acute myocardial infarction.
- Metabolic consequences of glucose-insulin-potassium infusion in treatment of Acute myocardial infarction.
- Clinical experience with glucose-insulin-potassium therapy in Acute myocardial infarction.
- Enhancement of left ventricular function by glucose-insulin-potassium infusion in Acute myocardial infarction.
- Glucose-insulin-potassium induced alterations in individual plasma free fatty acids in patients with Acute myocardial infarction.
- Clinical effects of glucose-insulin-potassium on left ventricular function in Acute myocardial infarction: results from a randomized clinical trial.
- Acute effects of glucose-insulin-potassium infusion on myocardial substrates, Coronary blood flow and oxygen consumption in man.
- Improved myocardial contractility with glucose-insulin-potassium infusion during pacing in coronary artery Disease.
- Reduction in coronary heart Disease: clinical and anatomical considerations.
- Glucose-insulin-potassium, free fatty acids and Acute myocardial infarction in man.
- Glucose-insulin-potassium administration in Acute myocardial infarction.
- Autoantibody titers to oxidized low-density lipoprotein in patients with Coronary atherosclerosis.
- Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery Disease. Studies on myocardial carbohydrate, lipid ...
- Elderly patients at risk for coronary heart Disease or stroke: selecting an ideal product for lipid lowering.
- LEFT VENTRICULAR VOLUMES IN VALVULAR HEART Disease.
- Evidence for endothelial dysfunction and enhanced vasoconstriction in Myocardial bridges.
- Myocardial salvage after failed Coronary angioplasty.
- Coronary artery Disease in women. Risk factors, evaluation, treatment, and prevention.
- Coronary artery Disease in the elderly.
- The cardiac catheter: past, present and future.
- Progressive Heart failure secondary to a high output state.
- Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery Disease in postmenopausal women.
- Cholesterol and lipoproteins: beyond atherogenesis.
- Effects of high-density lipoprotein on acetylcholine-induced Coronary vasoreactivity.
- Consequences of estrogen deprivation and the rationale for hormone replacement therapy.
- Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery Disease in women.
- Estrogen and coronary artery Disease in postmenopausal women.
- Current status of hemodynamic monitoring: indication, diagnoses, complications.
- Metabolic support during Coronary reperfusion.
- Left ventricular size and function and Heart size in the year following myocardial infarction.
- Pulmonary capillary thrombosis in septicemia due to gram-positive bacteria.
- Early surgical treatment of valvular Endocarditis.
- Determinants of cardiac Failure after coronary bypass surgery within 30 days of acute myocardial infarction.
- Coronary revascularization surgery: feasibility after myocardial infarction.
- Myocardial infarction in patients less than 45 years old: Acute course, angiographic findings, and long-term follow-up.
- New arterial Hypertension during myocardial infarction.
- Unstable angina pectoris: management based on available information.
- Unstable angina pectoris: is it time to change our approach?
- Intramitochondrial inclusions in the myocardial cells of human hearts and coronary Disease.
- Unstable angina pectoris: an examination of modes and costs of therapy.
- Improved outcome for prehospital cardioPulmonary collapse with resuscitation by bystanders.
- Effect of heparin-induced free fatty acid elevation on Myocardial oxygen consumption in man.
- Coronary anatomy and arteriography in patients with unstable angina pectoris.
- Surgical vs nonsurgical management of patients after Myocardial infarction.
- Energy dependent insulin binding, internalization and degradation in isolated cardiac myocytes from normal and diabetic rats.
Schools
Duke University
Duke Hospital
King Co Hospital
University Wash Hospital
VA Hospital
Procedures Preformed
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- Cardioversion, Elective
- Chest CT (incl. Heart and Lungs)
Conditions Treated
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- Cardiomyopathy
- Carotid Artery Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
- Elected Member
- Distinguished Alumnus
- President
- Fellow (FACC)
Education
-
Duke University Hospital -
University of Washington -
Duke University School of Medicine
Hospital
-
MedStar Washington Hospital Center -
MedStar Georgetown University Hospital
Drug Facts
| NPI NUMBER | 1992781637 | |
| NPPES Provider LastName | RACKLEY | |
| NPPES Provider FirstName | CHARLES | |
| NPPES Provider ZIPCode | 200072113 | |
| NPPES Provider State | DC | |
| Specialty Description | Cardiology | |
| Total Claim Count | 1179.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 1.1 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1992781637 |
| Last Name Of The Provider | RACKLEY |
| First Name Of The Provider | CHARLES |
| View All |
Similar Doctors
|
|
Dr. Patrick M. Looser, MD |
|
|
Dr. James B. Strait III, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Pearle, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Marco A. Mercader, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bernard Ashby, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Allison W. Warren, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Georgia S. Willie-Carnegie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mitchell B. Schwartz, MD
This Doctor is OpenDoctor Recommended.
|